216 related articles for article (PubMed ID: 29050328)
1. Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.
Wang J; Liu Y; Zhang N; Li X; Xin P; Bi J; Kong C
Oncotarget; 2017 Sep; 8(41):70874-70882. PubMed ID: 29050328
[TBL] [Abstract][Full Text] [Related]
2. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma.
Wu S; Wan Q; Xu R; Zhu X; He H; Zhao X
Oncotarget; 2017 Oct; 8(53):91694-91702. PubMed ID: 29207678
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis.
Li DY; Hao XY; Ma TM; Dai HX; Song YS
Sci Rep; 2017 Nov; 7(1):15387. PubMed ID: 29133845
[TBL] [Abstract][Full Text] [Related]
6. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
7. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
8. Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis.
Zhou LH; Luo XF
Clin Chim Acta; 2017 Nov; 474():102-107. PubMed ID: 28903023
[TBL] [Abstract][Full Text] [Related]
9. Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.
Gu X; Gao XS; Qin S; Li X; Qi X; Ma M; Yu H; Sun S; Zhou D; Wang W; Xiong W
PLoS One; 2016; 11(9):e0163523. PubMed ID: 27658306
[TBL] [Abstract][Full Text] [Related]
10. The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.
Wang X; Su S; Guo Y
Oncotarget; 2017 Oct; 8(48):84506-84514. PubMed ID: 29137443
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
Li W; Tao L; Lu M; Xiu D
Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis.
Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
Onco Targets Ther; 2016; 9():869-76. PubMed ID: 26955285
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.
Gu X; Sun S; Gao XS; Xiong W; Qin S; Qi X; Ma M; Li X; Zhou D; Wang W; Yu H
Sci Rep; 2016 Mar; 6():23893. PubMed ID: 27025911
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis.
Wang X; Ni X; Tang G
Front Oncol; 2019; 9():757. PubMed ID: 31475109
[No Abstract] [Full Text] [Related]
15. Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis.
Zhao QT; Zhang XP; Zhang H; Duan GC
Oncotarget; 2017 Dec; 8(67):112085-112093. PubMed ID: 29340113
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of the Platelet-to-Lymphocyte Ratio in Patients With Melanoma: A Meta-Analysis.
Zhang F; Gong W
Front Oncol; 2020; 10():1116. PubMed ID: 32850320
[No Abstract] [Full Text] [Related]
17. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
[TBL] [Abstract][Full Text] [Related]
18. Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer.
Lu C; Gao P; Yang Y; Chen X; Wang L; Yu D; Song Y; Xu Q; Wang Z
Oncotarget; 2017 Oct; 8(49):86287-86295. PubMed ID: 29156795
[TBL] [Abstract][Full Text] [Related]
19. The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis.
Ma XM; Sun X; Yang GW; Yu MW; Zhang GL; Yu J; Zhang Y; Wang XM
Climacteric; 2017 Oct; 20(5):448-455. PubMed ID: 28569074
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort.
Ding N; Pang Z; Shen H; Ni Y; Du J; Liu Q
Sci Rep; 2016 Oct; 6():34823. PubMed ID: 27703265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
